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ABSTRACT
The loss of photoreceptors is a major concern implicated in age-macular degeneration (AMD), a type of neurodegenerative 
disorder. Failure to prescribe a suitable treatment due to the lack of understanding of the molecular pathogenesis, and 
limited capacity to compensate irreparably damaged photoreceptors in the retina have greatly contributed to the 
progression of visual dysfunction. Our previous study has shown that Mesenchymal Stem Cells (MSCs) expressing 
erythropoietin (EPO) could commit into photoreceptor cell lineage. However, the efficiency of cell differentiation is 
limited. The present study aims to explore the capacity of these MSCs to form neurospheres. The cells were transduced 
with lentiviral particles encoding for human EPO and green fluorescent protein (GFP) genes, culture-expanded and 
sorted before subjected for differentiation induction into neural precursor cells. Our results showed that MSC-EPO 
developed into larger neurosphere and expressed relatively higher expression of nestin compared with MSCs alone when 
cultured under neural induction medium. These preliminary findings suggested that MSC-EPO have greater neurogenic 
potential than MSCs alone. Further study is needed to evaluate the possibilities of neurosphere to delete differentiate 
into functional photoreceptor cells. We believe that the success of neurosphere expansion may potentially be useful in 
scaling up the manufacturing of photoreceptors in a shorter time and at an efficient cost for retinal cell replacement 
therapy. 
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ABSTRAK
Kehilangan fotoreseptor menjadi kebimbangan utama dalam degenerasi makro-usia (AMD), sejenis gangguan 
neurodegeneratif. Perkembangan disfungsi visual berlaku apabila terdapat kegagalan untuk memberi rawatan yang 
sesuai akibat kekurangan pemahaman dalam patogenesis molekul dan keupayaan terhad untuk mengganti kerosakan 
fotoreseptor di retina. Kajian terdahulu menunjukkan bahawa Sel Stem Mesenkima (MSC) yang mengungkapkan 
eritropoletin (EPO) boleh berkembang menjadi sel berketurunanan fotoreseptor. Walau bagaimanapun, kecekapan 
pembezaan sel adalah terhad. Kajian ini bertujuan untuk meneroka keupayaan MSCs untuk membentuk sfera neuro. Sel 
telah ditransduksi dengan zarah lentiviral yang mengekod gen manusia protein EPO dan hijau neon (GFP), 
diperbanyakkan melalui pengkulturan sel dan ditulen sebelum induksi diferensiasi ke sel prekursor saraf. Keputusan 
kami menunjukkan bahawa MSC-EPO berkembang menjadi sfera neuro yang lebih besar dan menunjukkan ekspresi 
nestin yang lebih tinggi berbanding dengan MSC sahaja apabila dikultur di dalam medium induksi saraf. Penemuan 
awal ini mencadangkan bahawa MSC-EPO mempunyai potensi neurogen yang lebih besar daripada MSC sahaja. Kajian 
lanjut diperlukan untuk menilai kebolehan sfera neuro untuk membeza seterusnya kepada sel-sel fotoreseptor yang 
berfungsi. Kami percaya bahawa kejayaan pengembangan sfera neuro berpotensi digunakan untuk meningkatkan 
produksi fotoreseptor dalam masa yang lebih singkat dan pada kos yang cekap untuk terapi penggantian sel retina.
Kata kunci: Eritropoletin; fotoreseptor; pembezaan neural; sel stem mesenkima; sfera neuro
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Introduction
A permanent loss of neurons is a common pathology 
observed in the late-onset of multiple irreversible 
conditions in neurodegenerative diseases including 
Alzheimer’s disease (Ding et al. 2011), Parkinson’s disease 
(Wyse et al. 2014), multiple sclerosis (Borhani Haghighi 
et al. 2012) and age-macular degeneration (AMD) 
(Schwartz et al. 2016). Despite the increase in lifespan of 
global population due to advances in the provision of 
medical healthcare, there is a lack of efficient treatments 
that could halt or delay the progression of these diseases. 
Our body possess limited capability to regenerate new 
neuronal cells (Klassen 2015). Hence, the idea to replace 
or repair destructive neurons by use of stem cells 
replacement therapy is rational.  
Tremendous works have been dedicated to research 
into possible use of Mesenchymal Stem Cells (MSCs) for 
countering visual loss in the elderly due to AMD (Ding et 
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al. 2019a; Mok et al. 2017). MSCs represents a reliable cell 
source that has multipotent differentiation potential, within 
and beyond its mesodermal lineage, to form different cell 
types. In our previous studies, we showed that when MSCs 
were transplanted into a transgenic rat model that exhibit 
retina degeneration, some of these cells formed retina 
neuronal cells (Leow et al. 2015). In an in vitro study, we 
showed that these cells could be better coaxed into retinal 
photoreceptor cells when introduced with erythropoietin 
(EPO) gene (Ding et al. 2019a). Similar to other studies 
that demonstrated successful MSC differentiation into other 
neuronal cells (Danielyan et al. 2009; Hayashi 2013; 
Roozafzoon et al. 2015), the limited photoreceptor cell 
yield remains one major obstacle in achieving sufficient 
visual function improvement.  
Hence, the current study is a follow-up initiative to 
find methods to upscale the production of photoreceptors 
in the laboratory (Ding et al. 2019a). Instead of direct 
differentiation, we hypothesized that MSC-EPO could be 
differentiated into neurosphere before further induction to 
produce larger number of photoreptors. To do this, we 
incubated MSC-EPO in a specific neurogenic differentiation 
culture medium and determined its potential ability to form 
neurospheres. The EPO gene was transduced along with 
green fluorescence protein (GFP) reporter gene into the 
MSCs which were derived from human Wharton’s Jelly 
(hWJ-MSCs). The results demonstrated that the transduced 
hWJ-MSCs could form larger neurosphere and expressed 
relatively more intense nestin marker compared with non-
transduced cells. This study is important to provide 
experimental foundation for application of MSC expressing 
EPO to efficiently generate neural progenitor cells, helpful 
in upscaling the manufacturing of photoreceptor cells in 
the future. 
Materials and Methods
cell culture and characterization of msc-epo
The MSCs used in this experiment were derived from 
human Wharton’s Jelly, a gift from Cryocord Sdn. Bhd. 
(Malaysia) in the form of cryovial, with written, informed 
consent from patient donors. The cells were culture-
expanded and characterized as described in previous 
publications from our laboratory (Ding et al. 2019a). These 
cells were then transduced by lentiviral particles encoding 
EPO gene according to a procedure mentioned in a prior 
report (Ding et al. 2019a). The transduced cells were 
cryopreserved in liquid nitrogen at -180°C until used for 
further experiments. 
spontaneous differentiation of neurospheres from 
mscs and epo-expressing mscs
Prior to neurosphere differentiation experiment, the 
transduced MSC-EPO cells were purified by two to three 
rounds of passaging and sorting by using a flow cytometer 
sorter (BD FACSAria III) (BD Biosciences). The transduced 
MSC-EPO cells were then cultured in single cell suspension 
at a seeding concentration of 5 × 105 cells/cm2 in a 10 cm 
sterile low adherence petri dish (Fisher Scientific) 
containing 5 mL of neural induction medium. The neural 
induction medium was prepared by supplementing 1 × 
Glasgow Minimum Essential medium (GMEM; Gibco) 
with 2.3% sodium bicarbonate, 1 mM of L-glutamine 
(Gibco), 0.5 mM of sodium pyruvate (Gibco), 1× non-
essential amino acids (NEAA; Gibco), 0.1 mM of 
β-mercaptoethanol (Gibco), and 15% heat-inactivated FBS 
(Gibco). Two mL of fresh neural induction medium was 
added to the cultured cells in every three alternating day. 
Following incubation at approximately 8 days, the floating 
cell aggregates were collected using a Pasteur pipette. The 
aggregates were then transferred into a gelatin pre-coated 
24-well plate for immunocytochemical staining. Prior to 
that, the gelatin-coated plates were prepared by the addition 
of 300 µL of gelatin solution at 0.1% into each well and 
incubated at 25°C for 2 h. Following incubation, coating 
solution was discarded and the wells were washed gently 
with 1 × of sterile PBS for twice. The coated plates were 
sealed with Parafilm and kept at 4°C until identification of 
neurosphere aggregates by immunocytochemical staining.
immunocytochemical staining of differentiated 
mscs and epo-expressing mscs
The differentiation potential of MSCs and MSC-EPO into 
neural precursor cells in the neurospheres was assessed by 
immunocytochemical staining with primary antibodies 
specific for neural precursor cell marker, nestin. Briefly, 
the supernatant of MSC culture medium was discarded and 
cells were washed three times with 1 × sterile PBS before 
fixation by 4% paraformaldehyde pH7.4 (Sigma) at 25ºC 
for 15 min. After that, the fixative was aspirated and the 
cells were washed three times with cold sterile PBS in 0.1% 
Tween 20 (PBST). The cells were then incubated with 0.1% 
Triton X-100 in PBS for 10 min to permeablize the cells. 
Then, the cells were washed three times in 0.1% PBST 
solution before blocking by incubation with 1% BSA 
blocking buffer in 0.1% PBST for 30 min. 
After removal of blocking buffer, spherical cell 
aggregates were stained with mouse monoclonal anti-nestin 
primary antibody (Millipore; 1:200) for 16 h, in 4°C chiller. 
The staining solution was prepared freshly by diluting 6 
µL of primary antibody nestin in 1% BSA blocking buffer 
to a final volume of 1.2 mL and each well was filled to a 
final volume of 300 µL containing diluted anti-nestin 
antibody. Following incubation, the cells were washed 
several times in 0.1% PBST solution and conjugated with 
secondary antibody Alexa Fluor 594 goat anti-mouse IgG 
(Merck Millipore; Darmstadt, Germany) in 1% BSA 
blocking buffer at 1:400 dilution. The plate was covered 
with aluminium foil for 1 h at 25°C, followed by, repeated 
washing in 0.1% PBST buffer solution for 3 times. Lastly, 
4% paraformaldehyde fixative solution was added to the 
cells for microscopic examination under inverted 
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fluorescence microscope. The intensity of nestin expression 
on the cell clusters was measured by ImageJ software 
(National Institute of Health; USA) after normalization with 
DAPI stain. The mean expressions of nestin in the cell 
clusters derived from both unmodified MSCs and MSC-EPO 
were then compared, and its significant difference was 
determined by unpaired T-test using Prism 5.0 (GraphPad).
Results and Discussion
Mesenchymal stem cells (MSCs) has emerged as a suitable 
choice for replacement of retinal cells, particularly the 
photoreceptors (Leow et al. 2015) and retinal pigmented 
epithelial cells (Alsaeedi et al. 2019), which are highly 
affected in AMD progression (Bhutto & Lutty 2012). 
Despite many reported methods to generate photoreceptors 
in vitro or direct cell transplantations (Ding et al. 2017), 
achievement of treatment outcomes remained far from 
ideal. One of the challenges has been the low differentiated 
cell yield, as observed from in vitro works. 
In our previous study, we have evinced that introduction 
of EPO could significantly increase the differentiation of 
MSCs into photoreceptors (Ding et al. 2019b). The MSCs 
were derived from human Wharton’s Jelly and characterized 
by using flow cytometry in prior (Ding et al. 2019b). MSCs 
population showed high expression for CD90, CD73, 
CD105, CD29, and HLA-ABC but largely negative for 
marker of haematopoietic cells including CD34, CD14, 
CD45, CD80, and CD86 (Ding et al. 2019b). Established 
cultures of MSCs at third passage were culture-expanded 
for subsequent transduction experiments with lentivirus 
vector encoding the human EPO and GFP reporter genes. 
The transduced cells were culture-expanded and the 
expression of GFP was monitored by a fluorescence 
microscope. Meanwhile, the flow cytometer indicated 
13.0% of the cells exhibited green fluorescence. Prior to 
neurosphere differentiation, the transduced cells (GFP+ 
cells) were purified by using a flow cytometer sorter 
(Figure 1). 
Neurospheres are neural progenitor cells which can 
undergo fate specification to form other type of mature 
retinal neuronal cells (Chung et al. 2013; Ji et al. 2017; 
Leite et al. 2014; Ma et al. 2011; Mung et al. 2016; Yang 
et al. 2015), important for phototransduction. Various cell 
culture techniques have been adopted to ensure a close 
physiological resemblance that may influence neuronal 
cell fate and differentiation (Gupta et al. 2016). Among all 
cell culture systems, MSCs cultured as floating spherical 
aggregates referred as neurospheres were found to direct 
into neural cell lineage effectively when compared to 
conventional culture method (Portmann-Lanz et al. 2010; 
Zhou et al. 2016). Coupled with the induced expression of 
EPO, this technique may serve as a potential strategy to 
increase the yield of neurospheres and ensure survivability 
of cells upon transplantation in a patient. Additionally, the 
advantage of differentiation into neurospheres also lies on 
its potential to be expanded before subjected to further 
induction into terminally differentiated cells, hence, 
increasing production of photoreceptor cell yield.
With reference to a protocol reported previously (Mun-
Fun et al. 2015) and with slight modifications, we found 
that the MSCs and MSC-EPO in suspension culture were 
capable of developing into clusters of neurosphere (Figure 
2). MSCs and MSC-EPO were analysed for their neural 
differentiation potential by culturing sorted cells for eight 
days to form neurosphere in suspension. During neural 
induction, morphological changes in MSCs and MSC-EPO 
cultures were captured as two-dimensional microscopic 
images at different time points (Figure 2). Cultured cells 
propagated into a small, floating-clustered cell with 
irregular edges, while cells that failed to form cluster died 
and sediment on the bottom of the culture plate two days 
FIGURE 1. Flow cytometry data representing transduction efficacy of non-transduced (red plot) and EPO-transduced (blue plot) 
MSCs based on the GFP+ intensity in each gated MSC population from the non-transduced MSCs (GFP-). Data are representative 
of four independent transduction experiments. An isotype control was employed in the experiment to eliminate background 
fluorescence. The GFP+ cells were sorted for downstream experiment to induce neurosphere formation
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after initial cell plating (Figure 2). The spherical cellular 
aggregates showed various sizes, ranging from 150 µm to 
230 µm for MSCs and from 180 µm to 400 µm for MSC-
EPO. Some of the neurospheres formed from MSC-EPO 
showed appearance of groups of cells at the boundary. After 
8 to 10 days of neural induction, the neurospheres showed 
well-defined boundary around the edge and exhibited dark 
core in the centre (Figure 2(G) and Figure 2(H)). 
From the immunocytochemical analysis in Figure 3, 
the expression of nestin, an early neural progenitor cell 
marker, were detected in aggregates formed by MSC-EPO 
and MSCs. This indicates that transduction did not hamper 
differentiation of MSCs into neural progenitor. Furthermore, 
neurospheres formed from MSC-EPO constitutively 
expressed GFP (Figure 3(G)) suggesting that the neural 
differentiation of MSC-EPO did not affect the EPO gene 
expression. Also, neurosphere-derived from MSC-EPO 
appeared larger in size and exhibited significantly higher 
expression (p < 0.01) for neural stem or progenitor marker, 
nestin, as compared with those derived from unmodified 
MSCs (Figure 3(F) & 3(B)). 
The disparity between the neurospheres formed 
between MSCs and MSC-EPO was most likely due to the 
release of secretory EPO protein from MSC-EPO (Figure 
3). It is noteworthy that EPO has long been recognized to 
also participate in neurogenesis and anti-apoptotic activities 
(Eckardt & Kurtz 2005; Lv et al. 2015; Zhang et al. 2007) 
to maintain various tissue functions (Chung et al. 2009; 
Shirley Ding et al. 2016). For example, EPO was found to 
be released in an autocrine manner from neural progenitor 
cells in a mouse model of spinal cord injury to sustain 
neural progenitor cell survivability under apoptotic 
microenvironment and upregulate neurogenesis (Carelli et 
al. 2016). Meanwhile, administration of EPO were 
demonstrated to increase precursor and mature neuronal 
cell differentiation in healthy young mouse models 
(Hassouna et al. 2016). Therefore, the larger spherical cell 
aggregates derived from MSC-EPO could be attributed to 
FIGURE 2. Morphological changes in neurosphere-derived from MSCs and MSC-EPO following to neural differentiation after 10 
days, in vitro. A time-point discrimination of neurosphere-like cell aggregates derived from MSCs and MSC-EPO were assessed on 
day 2, 6, 8, and 10, after initial cell plating. Note that floating sphere cultures formed a smooth edge with darkened centre, after 6 to 
8 days. Cells were imaged by phase-contrast microscopy at × 100 magnifications (scale bar, 200 μm)
FIGURE 3. Characterization of neurosphere-like aggregates cultured from MSCs and MSC-EPO after neural differentiation at day 
10. Morphological feature of neurosphere-like aggregates derived from MSCs (A) and MSC-EPO (E), respectively, after cell plating 
onto gelatin-coated plate. Both neurosphere-like aggregates were immunopositive for neural progenitor cell marker, nestin (red) (B 
& F). GFP expression (green) was only detected in neurosphere derived from MSC-EPO (G). Cell aggregates were counterstained 
with nuclear DAPI staining (blue) for cell nuclei localisation (D & H). Cells were imaged by fluorescence microscopy at × 100 
magnifications (scale bar, 200 μm)
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both enhanced neural differentiation and anti-apoptotic 
properties of EPO.
In the context of visual function repair, this study 
provided experimental foundation for application of MSC 
expressing EPO to efficiently generate neural progenitor 
cells, potentially helpful in upscaling the manufacturing 
of photoreceptor or other cell types such as RPE or 
ganglion cells in the future. More studies are needed to 
affirm these. Quantitative data are important to observe 
the changes of specific mRNA gene expression during 
development or maturation of these cell types, and to 
allow further optimization of cell production (Ovando-
Roche et al. 2018). Also, functional studies using animal 
models will be needed to shed light on the state of cell 
integration in neural circuits. Noteworthy of mentioning 
is these neurospheres can be used for directed 
differentiation into cholinergic- (Danielyan et al. 2009) 
and dopaminergic- (Chun et al. 2016; Hayashi et al. 2013) 
neurons, Schwann cells (Faroni et al. 2016) or neuro-glial 
cells (Miceli et al. 2016; Radtke et al. 2009) at larger 
quantities, to cure other neurodegenerative diseases too 
(Figure 4). 
In conclusion, lentiviral encoding for erythropoietin 
(EPO) gene were successfully transduced into mesenchymal 
stem cells derived from human Wharton’s jelly of umbilical 
cord. The secreted EPO protein could enhance cell 
differentiation into neural progenitor cell fate following 
neurosphere induction with neural induction medium. 
Taken together, the current study provides a rational 
strategy whereby utilisation of MSCs expressing EPO (MSC-
EPO) would provide a potential strategy for MSCs 
differentiation into neural cell fate to achieve a successful 
cell replacement therapy in future clinical setting involving 
neurodegenerative diseases.
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FIGURE 4. Comparison of differentiation methods using Mesenchymal Stem Cells (MSCs) expressing erythropoietin (MSC-
EPO) into photoreceptors. Direct differentiation can generate photoreceptors with limited yield. By inducing MSC-EPO to 
form neurospheres, a type of neural progenitor cell, the production of photoreceptors can be largely upscaled. In addition, the 
neurospheres can be expanded and cryopreserved until further downstream differentiation to form other types of neuronal cells, e.g. 
cholinergic- or dopaminergic neurons, Schwann cells, neuro-glial cells, or other retinal neuronal cells. Erythopoietin has important 
role in promoting neurogeneis and anti-apoptosis
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